Top compounds associated with response to TMEM229A


Feature Type Standardized
Nominal ANOVA
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.0017 1
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.0016 1
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.0016 1
mRNA MI-2 CTRPv2 pan-cancer AAC 0.002 1
mRNA nintedanib CTRPv2 pan-cancer AAC -0.0012 1
mRNA LFM-A13 GDSC1000 pan-cancer AAC -0.0011 1
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.0011 1
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.001 1
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.0014 1
mRNA AT7867 CTRPv2 pan-cancer AAC -0.00087 1
Download CSV